The Future of Antiviral Chemotherapy

Over the past two decades, alongside the production of vaccines against many viruses, effective drugs have been developed for many other common viral infections. Initially, many of these drugs were available only for topical application because of their toxicity. However, advances in our knowledge o...

Descripción completa

Detalles Bibliográficos
Autores principales: Crowe, Suzanne, Mills, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 1988
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135513/
https://www.ncbi.nlm.nih.gov/pubmed/3067915
http://dx.doi.org/10.1016/S0733-8635(18)30631-4
Descripción
Sumario:Over the past two decades, alongside the production of vaccines against many viruses, effective drugs have been developed for many other common viral infections. Initially, many of these drugs were available only for topical application because of their toxicity. However, advances in our knowledge of viral replication and of the molecular and cellular mechanisms of antiviral action have identified virus-specific targets for chemotherapeutic intervention with fewer side effects.

Ejemplares similares